Granules India Limited
Granules India Limited (India) holds 57 active US FDA Type II Drug Master Files and 17 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 5 FDA-registered manufacturing sites. 4 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Granules India Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/granules-india-limited
Overview
Granules India Limited is a pharmaceutical manufacturing company that specializes in the production of APIs, pharmaceutical formulation intermediates, and finished dosages. The company is committed to providing cost-effective, high-quality pharmaceutical products and is recognized for its efficient operations and robust supply chain management.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Granules India Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Granules India Limited holds 57 active (74 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- ELACESTRANT DIHYDROCHLORIDEActive2026-09-12
- RUXOLITINIB HYDROCHLORIDEActive2026-06-05
- FRUQUINTINIBActive2026-03-30
- GABAPENTIN USPActive2026-03-30
- SERDEXMETHYLPHENIDATE CHLORIDEActive2026-03-28
- ABEMACICLIBActive2026-03-23
- AVATROMBOPAG MALEATEActive2025-07-01
- LISDEXAMFETAMINE DIMESYLATEActive2025-05-17
- CALCIUM OXYBATEActive2025-03-31
- SODIUM OXYBATEActive2025-03-31
- POTASSIUM OXYBATEActive2025-03-31
- RUXOLITINIB PHOSPHATEActive2025-02-12
- VILOXAZINE HYDROCHLORIDEActive2024-09-30
- MAGNESIUM OXYBATEActive2024-03-31
- EMPAGLIFLOZINActive2024-03-29
- RIFAXIMIN PH. EURActive2024-03-07
- LINAGLIPTINActive2024-01-14
- ELTROMBOPAG OLAMINEActive2023-12-31
- DAPAGLIFLOZINActive2023-12-30
- DASATINIB MONOHYDRATEActive2023-03-31
- LEVETIRACETAM USPActive2022-12-30
- TRAZODONE HYDROCHLORIDE USPActive2022-12-28
- OMEPRAZOLE USPActive2022-09-29
- ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE PELLETS (25.82% W/W)Active2022-07-01
- SORAFENIB TOSYLATE USPActive2022-06-30
- PANTOPRAZOLE SODIUM SESQUIHYDRATE, USPActive2022-05-19
- OLMESARTAN MEDOXOMIL USPActive2022-03-31
- ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, USPActive2021-12-24
- RIFAXIMIN (RSA CODE)Active2021-08-29
- COMPRESSO LSP 33.333 % (LOSARTAN POTASSIUM DIRECTLY COMPRESSIBLE GRANULES)Active2021-07-12
- PAZOPANIB HYDROCHLORIDEActive2021-06-30
- COMPRESSO IBU 85 PAR (IBUPROFEN GRANULES DC 85 %)Active2021-05-18
- BUPROPION HYDROCHLORIDE USPActive2021-03-29
- VIGABATRIN, USPActive2020-12-29
- DASATINIBActive2020-11-23
- PRAZOSIN HYDROCHLORIDE USPActive2020-09-30
- BORTEZOMIBActive2020-01-31
- METOPROLOL SUCCINATE USPActive2019-03-27
- ATAZANAVIR SULFATEActive2017-12-27
- PENICILLAMINE, USPActive2017-11-03
- OMEPRAZOLE MAGNESIUM USPActive2017-08-31
- PIRFENIDONEActive2016-09-30
- DIMETHYL FUMARATEActive2016-09-27
- FEXOFENADINE HYDROCHLORIDE, USPActive2016-08-16
- CETIRIZINE HYDROCHLORIDE, USPActive2016-02-01
- LEVOCETIRIZINE DIHYDROCHLORIDE USPActive2009-05-22
- LOSARTAN POTASSIUM USPActive2009-04-02
- COMPRESSO GGF 95 SA (GUAIFENESIN GRANULES 95%)Active2007-10-31
- COMPRESSO IBU 66SActive2007-06-12
- COMPRESSO PAP 90 CPCActive2006-11-16
Showing the 50 most relevant of 74 Drug Master Files (active first). The full list is in the FDA DMF list.
Registered manufacturing sites (5)
Physical sites registered with the US FDA and resolved to Granules India Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
- Granules India LimitedSangareddy, India · API manufacture
- Granules India LimitedMedchal-Malkajgiri District, India · API manufacture
- Granules India LimitedAnakapalli, India · API manufacture
- Granules India LimitedAnakapalli, India · API manufacture
- GRANULES LIFE SCIENCES PRIVATE LIMITEDShameerpet Medchal-Malkajgiri, India · Analytical testing · LabellingSite GMP match
FDA compliance signals
4 FDA enforcement records linked to this company.
- warning_letter2025-02-26
FDA Warning Letter (drug product)
- 4832020-02-14
Investigations of discrepancies, failures
- 4832020-02-14
Calibration/Inspection/Checking not done
- recall — Class II2020-01-08
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Is this Granules India Limited?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.